Frontiers in Pharmacology | Pharmacology of Infectious Diseases

Original Research

Published on 11 Apr 2024

In vitro pharmacokinetics/pharmacodynamics of FL058 (a novel beta-lactamase inhibitor) combined with meropenem against carbapenemase-producing Enterobacterales

in Pharmacology of Infectious Diseases

Zhiwei Huang
Xingchen Bian
Yi Li
Jiali Hu
Beining Guo
Xinyi Yang
Yi Jin
Shansong Zheng
Xinmei Wang
Cong Gao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1282480

1,429 views
2 citations

Original Research

Published on 10 Apr 2024

Physalin H, physalin B, and isophysalin B suppress the quorum-sensing function of Staphylococcus aureus by binding to AgrA

in Pharmacology of Infectious Diseases

Junpei Yamaguchi
Teruhisa Manome
Yasumasa Hara
Yuriko Yamazaki
Yuumi Nakamura
Masami Ishibashi
Akiko Takaya

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365815

2,132 views
1 citation

Original Research

Published on 09 Apr 2024

Phage-antibiotic combinations in various treatment modalities to manage MRSA infections

in Pharmacology of Infectious Diseases

Archana Loganathan
Bulent Bozdogan
Prasanth Manohar
Ramesh Nachimuthu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1356179

5,213 views
10 citations

Review

Published on 02 Apr 2024

Inhibitory effect of natural compounds on quorum sensing system in Pseudomonas aeruginosa: a helpful promise for managing biofilm community

in Pharmacology of Infectious Diseases

Aref Shariati
Milad Noei
Marzieh Askarinia
Amin Khoshbayan
Abbas Farahani
Zahra Chegini

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1350391

7,001 views
8 citations

Original Research

Published on 21 Mar 2024

The synergistic antibacterial activity and mechanism of colistin-oxethazaine combination against gram-negative pathogens

in Pharmacology of Infectious Diseases

Jie Li
Ning Han
Yangyang Li
Feifei Zhao
Wenguang Xiong
Zhenling Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363441

1,945 views
5 citations

Original Research

Published on 20 Mar 2024

Evaluating cardiac disorders associated with triazole antifungal agents based on the US Food and Drug Administration Adverse Event reporting system database

in Pharmacology of Infectious Diseases

Jinhua Chen
Shijun Xu
Weijiang Yu
Cuicui Sun
Wenzhou Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1255918

3,463 views
3 citations

Editorial

Published on 12 Mar 2024

Editorial: The evolution in pharmacology of infectious diseases: 2022

in Pharmacology of Infectious Diseases

Exequiel O. J. Porta
Ali Saffaei
Karunakaran Kalesh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1386077

1,521 views

Editorial

Published on 12 Mar 2024

Editorial: Treatment of tick-borne diseases: current status, challenges, and global perspectives

in Pharmacology of Infectious Diseases

Ketsarin Kamyingkird
Mohamed Z. Sayed-Ahmed
Mohamed Abdo Rizk

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366988

941 views
1 citation

Review

Published on 08 Mar 2024

Research progress on the PEGylation of therapeutic proteins and peptides (TPPs)

in Pharmacology of Infectious Diseases

Chunxiao Li
Ting Li
Xinya Tian
Wei An
Zhenlong Wang
Bing Han
Hui Tao
Jinquan Wang
Xiumin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1353626

6,966 views
19 citations

Original Research

Published on 07 Mar 2024

Adverse reactions induced by MDT/WHO (Rifampicin+Clofazimine+Dapsone) and ROM (Rifampicin+Ofloxacin+Minocycline) regimens used in the treatment of leprosy: a cohort study in a National Reference Center in Brazil

in Pharmacology of Infectious Diseases

Isadora Costa Celestino
Douglas Eulalio Antunes
Diogo Fernandes Santos
Victor Lemos Gimenes
Fabiane Mian de Souza
Isabela Maria Bernardes Goulart

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346169

4,784 views
2 citations

Original Research

Published on 28 Feb 2024

Chiral phthalimides against penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus: molecular docking and in vitro analysis

in Pharmacology of Infectious Diseases

Aamina Azam Khan
Momin Khan
Sher Wali Khan
Nayyer Siddique
Rimsha Abid
Shandana Zulfiqar
Sidra Rahman
Muhammad Ali

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1293458

2,358 views
1 citation

Original Research

Published on 26 Feb 2024

Retrospective analysis of pediatric sepsis and the burden of antimicrobial resistance in Duhok, Kurdistan Region of Iraq

in Pharmacology of Infectious Diseases

Delveen R. Ibrahim
Abdulrhaman T. Saadi
Nizar B. Yahya
Marwa S. Ibrahim
Ali Y. Saeed
Sawsan S. Abdulaziz
Revan Y. Hasqyal
Berivan K. Alarsalani
Khalid S. Ibrahim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1347832

2,124 views

Original Research

Published on 21 Feb 2024

Human adenovirus type 3 restores pharmacologically inhibited exosomal cargo in lung carcinoma cells

in Pharmacology of Infectious Diseases

Ayodeji O. Ipinmoroti
Rachana Pandit
Brennetta J. Crenshaw
Brian Sims
Qiana L. Matthews

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1339862

2,134 views

Review

Published on 16 Feb 2024

Study of alloferon, a novel immunomodulatory antimicrobial peptide (AMP), and its analogues

in Pharmacology of Infectious Diseases

Clara Appiah
Shitian Chen
Afia Ibnat Pori
Vladimir Retyunskiy
Chimeng Tzeng
Ye Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1359261

4,299 views
5 citations

Original Research

Published on 15 Feb 2024

The effectiveness of oral anti-SARS-CoV-2 agents in non-hospitalized COVID-19 patients with nonalcoholic fatty liver disease: a retrospective study

in Pharmacology of Infectious Diseases

Chun-Chi Yang
Ya-Wen Tsai
Su-Hung Wang
Jheng-Yan Wu
Ting-Hui Liu
Wan-Hsuan Hsu
Po-Yu Huang
Min-Hsiang Chuang
Ming-Jen Sheu
Chih-Cheng Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1321155

1,568 views
1 citation

Original Research

Published on 06 Feb 2024

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection

in Pharmacology of Infectious Diseases

Abdelrahim Maen
Betul Gok Yavuz
Yehia I. Mohamed
Abdullah Esmail
Jianming Lu
Amr Mohamed
Asfar S. Azmi
Mohamed Kaseb
Osama Kasseb
Dan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1291212

2,099 views
1 citation